According to Regencell Bioscience's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$6.1 Million, an increase over its 2023 earnings that were of -S$8.08 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2024 | -S$6.1 Million | -24.5% |
2023 | -S$8.08 Million | -17.64% |
2022 | -S$9.81 Million | 451.47% |
2021 | -S$1.78 Million | 70.04% |
2020 | -S$1.05 Million | 107.77% |
2019 | -S$0.51 Million |